CASTLE BIOSCIENCES, INC. Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
CASTLE BIOSCIENCES, INC. (CSTL) had Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year of $2.31 million as of 2022-09-30, per its 10-Q filed 2022-11-02.
Discontinued › Notes › Goodwill and Other
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear · last filed 2022-11-02
- 2022-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $2.31M.
- 2022-06-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $4.61M.
- 2022-03-31: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $5.03M.
- 2021-09-30: Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year $694.00K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year |
|---|---|
| 2022-09-30 | $2.31M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $4.61M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $5.03M 10-Q · filed 2022-05-09 |
| 2021-09-30 | $694.00K 10-Q · filed 2021-11-08 |
| 2021-06-30 | $1.39M 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |